Estate of LaMontagne v. Squibb

¶1 Juliann Dollmeyer, the personal representative of the Estate of Sandra LaMontagne (the Estate), appeals the trial court’s decision on summary judgment to dismiss the Estate’s prescription drug product liability claims against Bristol-Myers Squibb Company (BMS). The Estate contends there are material issues of fact about whether the “contraindication” section of the package insert for the prescription drug Glucophage® adequately warned doctors of the risks of lactic acidosis for Type II diabetic patients who also have kidney dysfunction. The Estate also contends there are material issues of…